BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3059053)

  • 21. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
    Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoid versus antiglucocorticoid activity: can a single functional group modification of glucocorticoid steroids always convey antiglucocorticoid activity?
    Lamontagne N; Mercier L; Pons M; Thompson EB; Simons SS
    Endocrinology; 1984 Jun; 114(6):2252-63. PubMed ID: 6547091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterisation of steroid receptor expression in the human prostate carcinoma cell line 22RV1 and quantification of androgen effects on mRNA regulation of prostate-specific genes.
    Hartel A; Didier A; Ulbrich SE; Wierer M; Meyer HH
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):187-97. PubMed ID: 15555912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correspondence factor analysis of steroid libraries.
    Ojasoo T; Raynaud JP; Doré JC
    Steroids; 1995 Jun; 60(6):458-69. PubMed ID: 7676479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrophilic 3 alpha,3 beta,17 beta,20 alpha-hydroxysteroid dehydrogenase from rabbit liver--II. Mechanisms of enzyme-steroid interaction.
    Smirnov AN
    J Steroid Biochem; 1990 Aug; 36(6):617-29. PubMed ID: 2214779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence of androgens in sewage treatment plants influents is associated with antagonist activities on other steroid receptors.
    Bellet V; Hernandez-Raquet G; Dagnino S; Seree L; Pardon P; Bancon-Montiny C; Fenet H; Creusot N; Aït-Aïssa S; Cavailles V; Budzinski H; Antignac JP; Balaguer P
    Water Res; 2012 Apr; 46(6):1912-22. PubMed ID: 22325933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A nonsteroidal glucocorticoid receptor antagonist.
    Miner JN; Tyree C; Hu J; Berger E; Marschke K; Nakane M; Coghlan MJ; Clemm D; Lane B; Rosen J
    Mol Endocrinol; 2003 Jan; 17(1):117-27. PubMed ID: 12511611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal conformations and receptor binding of some 9,11-modified estradiols.
    Palomino E; Heeg MJ; Horwitz JP; Polin L; Brooks SC
    J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):75-84. PubMed ID: 8049136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and conformation of glucocorticoids.
    Schmit JP; Rousseau GG
    Monogr Endocrinol; 1979; 12():79-95. PubMed ID: 386094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steroid structure and function. Molecular conformation of 4-hydroxyestradiol and its relation to other catechol estrogens.
    Wawrzak Z; Duax WL; Strong PD; Weisz J
    J Steroid Biochem; 1988 Apr; 29(4):387-92. PubMed ID: 3374127
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of steroid-protein interactions by dicyclohexane derivatives.
    Rousseau GG; Rolin Jacquemyns CF; Sirett DA; Huybrechts M; De Coen JL; Quivy JI
    J Steroid Biochem; 1988 Oct; 31(4B):691-7. PubMed ID: 3199813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-activity relationship of various endogenous estrogen metabolites for human estrogen receptor alpha and beta subtypes: Insights into the structural determinants favoring a differential subtype binding.
    Zhu BT; Han GZ; Shim JY; Wen Y; Jiang XR
    Endocrinology; 2006 Sep; 147(9):4132-50. PubMed ID: 16728493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor for glucocorticoids in RPMI 3460 melanoma cells.
    Hawkins EF; Horn D; Markland FS
    Cancer Res; 1980 Jul; 40(7):2174-8. PubMed ID: 7388784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on high affinity binding of mineralo- and glucocorticoids in rabbit aorta cytosol.
    Kornel L; Kanamarlapudi N; Travers T; Taff DJ; Patel N; Chen C; Baum RM; Raynor WJ
    J Steroid Biochem; 1982 Feb; 16(2):245-64. PubMed ID: 6281578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of the hormone-binding domain of steroid receptors using chimeras generated by homologous recombination.
    Martinez ED; Pattabiraman N; Danielsen M
    Exp Cell Res; 2005 Aug; 308(2):320-33. PubMed ID: 15936754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topographic recognition of cyclic hydrocarbons and related compounds by receptors for androgens, estrogens, and glucocorticoids.
    Chang CS; Liao SS
    J Steroid Biochem; 1987; 27(1-3):123-31. PubMed ID: 3695475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimineralocorticoid 11beta-substituted spirolactones exhibit androgen receptor agonistic activity: a structure function study.
    Nirdé P; Térouanne B; Gallais N; Sultan C; Auzou G
    Mol Pharmacol; 2001 May; 59(5):1307-13. PubMed ID: 11306716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter.
    Luo LY; Grass L; Diamandis EP
    Clin Chim Acta; 2003 Nov; 337(1-2):115-26. PubMed ID: 14568187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-activity analysis of binding kinetics for NMDA receptor competitive antagonists: the influence of conformational restriction.
    Benveniste M; Mayer ML
    Br J Pharmacol; 1991 Sep; 104(1):207-21. PubMed ID: 1686203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Steroid receptor profiling of vinclozolin and its primary metabolites.
    Molina-Molina JM; Hillenweck A; Jouanin I; Zalko D; Cravedi JP; Fernández MF; Pillon A; Nicolas JC; Olea N; Balaguer P
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):44-54. PubMed ID: 16750840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.